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Purpose: Due to the increasing numbers of radical prostatectomies (RP) performed for prostate cancer, a substantial and 
increasing number of patients suffer from postoperative urinary incontinence and erectile dysfunction (ED). The objective of our 
study was to see whether an inflatable penile prosthesis implantation could control urinary incontinence for patients with the dual 
problems of ED and incontinence.
Materials and Methods: From March 2010 through May 2015, 25 post-RP patients were referred to our clinic with ED or 
incontinence. The degree of incontinence was classified according to the International Consultation on Incontinence 
Questionnaire-Short Form. Inflatable penile prostheses were implanted in all 25 patients.
Results: For one month after implantation, partial or full inflation was performed progressively to control urine leakage. Of 18 
patients, 13 patients were categorized with mild or moderate stress incontinence. All 13 patients obtained control of incontinence 
with partial inflation (30% to 60%) and all reported satisfactory outcomes. Five out of the 18 patients were categorized with severe 
total incontinence. Three of the 5 patients could tolerate incontinence with full inflation on and off. Thirteen patients out of the 
total of 18 (72.2%) had their incontinence controlled by an inflating penile prosthesis.
Conclusions: An inflatable penile prosthesis is highly recommended as an initial procedure, especially in patients with the dual 
problems of ED and incontinence.
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INTRODUCTION
The prevalence of urinary incontinence in men is as 
high as 39% and increases with age [1]. The most preva-
lent cause of urinary stress incontinence in men is the radi-
cal prostatectomy (RP), a standard treatment for localized 
prostate cancer (PCa). Postoperative incontinence is one 
of the most adverse complications of RP, with a major im-
pact on quality of life. Due to the increasing number of RPs 
performed for PCa, a substantial and increasing number of 
patients suffer from postoperative stress incontinence.
With younger patients being diagnosed and living lon-
ger, there is an increasing demand for providing better 
health-related quality of life [2,3]. Despite improved surgi-
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Table 1. Characteristics of patients (n=25)
Characteristic Value
Age (yr) 69 (54∼78)
PSA (ng/dL) 0.02 (0.01∼0.05)
UFR (mL/s) 21 (10∼40)




By penile duplex ultrasonogram PSV＜30
Incontinence 18
By self-reporting ICIQ-SF score 14.6 (9∼21)
Values are presented as median (range) or number only.
PSA: prostate specific antigen, UFR: urinary flow rate, RP: 
radical prostatectomy, PSV: peak systolic velocity, ICIQ-SF: 
International Consultation on Incontinence Questionnaire- 
Short Form.
cal techniques of open, laparoscopic and robot-assisted 
RP, reported postoperative incontinence rates are be-
tween 5% and 48% [4,5]. This large variation in the rates 
of reported incontinence after RP may be attributed, to a 
certain extent, to the influence of the interviewing physi-
cian, as well as the lack of a standardized definition [6,7]. 
The treatment of post-prostatectomy incontinence con-
sists of three different approaches: conservative, pharma-
cotherapeutic, and surgical treatment. Continence may 
improve significantly during the first year after surgery and 
some studies show continued improvement within the 
first 2 years [8]. In general, surgical intervention should be 
considered if the status of incontinence is stable and there 
is no further improvement. The artificial urinary sphincter 
(AUS) is still the treatment of choice for persistent inconti-
nence. It has now been in clinical use for more than 30 
years. The success rate of the AUS is still highest compared 
with all other treatment options. The long-term results are 
very good, with success rates up to 90% [9]. Despite its re-
liability in treating urinary incontinence, the AUS is not 
perfect, with complication rates up to 12%, 15% for late 
erosion and 7% for delayed recurrent incontinence [10]. 
There are also many patients who present the combined 
problems of incontinence and erectile failure after RP. 
Walsh et al [11] introduced nerve-sparing RP, and re-
ported a postoperative potency rate 86% and continence 
rate of 93% [12].
It would be very advantageous if inflatable penile pros-
thesis implantation could prevent urinary incontinence in 
patients with both incontinence and erectile dysfunction 
(ED) since it is also an effective treatment for ED. To our 
knowledge, no reports are currently available about this 
new concept. With this idea in mind, the authors im-
planted inflatable penile prostheses as a first-line treat-
ment in those patients with the dual adverse outcomes of 
incontinence and ED after RP, and followed the treatment 
effect on urinary incontinence.
MATERIALS AND METHODS 
From March 2010 through May 2015, 25 patients were 
referred to our clinic with urinary incontinence or ED after 
RP, from 5 different university hospitals in Seoul, Korea.
Robot-assisted RP was performed in 11 patients and 
open retropubic RP was performed in 14 patients. The 
study design was approved by the IRB (Choi’s SS Clinic No 
1) and informed consent was obtained in all patients. In all 
patients, blood chemistry, urinalysis, urinary flow rates 
(UFR), International Consultation on Incontinence 
Questionnaire-Short Form (CIQ-SF) answers, prostate spe-
cific antigen (PSA), and penile duplex ultrasonogram were 
recorded. Under stable conditions, the mean PSA level 
was 0.02 ng/dL (0.01∼0.05 ng/dL). The mean maximum 
UFR was 21 mL/s (10∼40 mL/s). The degree of incon-
tinence was classified as follows, depending upon the 
scores of the ICIQ-SF: mild, 10 or less; moderate, from 11 
to 17; severe, 18 or more. Prostate ultrasonography and a 
cystoscopic exam were done in some patients with severe 
leaking. All 25 patients were diagnosed with vasculogenic 
ED by duplex ultrasonographic study, with poor peak arte-
rial systolic flow of less than 30 mL/s and findings of ve-
nous leakage. Out of 25 patients, 7 patients were con-
tinent and 18 patients were incontinent (Table 1).
Eighteen patients were classified according to the ICIQ- 
SF score as mild (5 patients), moderate (8 patients), or se-
vere (5 patients). The mean age of the patients was 69 
years (54∼78 years). The waiting time to visit our clinic af-
ter RP was, on average, 3 years and 4 months (6 months∼
10 years).
1. Surgical procedures 
For all 25 patients, an AMS 3-piece inflatable penile 
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Fig. 1. Endpoint-results.
prosthesis (American Medical System, MN, USA) was im-
planted under local anesthesia only (caudal, pudendal, 
ilioinguinal, and penile) in 20 patients and under spinal 
anesthesia in 5 patients. Due to severe post-RP fibrosis in 
the pelvic cavity, the reservoir insertion was somewhat 
difficult in 2 patients. In one patient, the reservoir had to 
be implanted under the rectus muscle. The other case was 
complicated by a hernia, resulting in secondary herniorr-
haphy. Except in the complicated cases, all patients were 
discharged that day or the following day.
The implanted size of the penile prosthesis was as fol-
lows: AMS CXR (American Medical System), 20 cases (14
∼18 cm) ; AMS CX (American Medical System), 5 cases 
(16∼18.5 cm). 
The mean length of the implanted prosthesis was 16.4 
cm. The mean follow-up duration was 2 years (3 months∼
4 years 6 months). After the operation, incontinence was 
re-evaluated by self-report and by a surgeon’s interview. 
For the primary endpoint, we asked “Do you still need a 
pad or other sanitary protection 24 hours per day?” For the 
secondary endpoint, we asked “What percent of penile in-
flation made you dry?”
RESULTS 
In 25 post-RP patients, 7 patients were continent and 18 
patients were incontinent. After implantation of the in-
flatable penile prosthesis, the 13 patients with stress in-
continence achieved completely pad-free status with 30% 
to 60% penile inflation. They willingly maintained the 
partial inflation status in their ordinary daily lives. Three 
patients were able to control leaking on and off only by full 
inflation. Two patients could not control leaking even 
with full inflation. One of them was disappointed with this 
outcome, and so received a secondary artificial sphincter 
implantation. The pad-free success rate was 72.2% (13/18 
patients) (Fig. 1).
These results show that in patients with the dual prob-
lems of ED and incontinence, an inflatable penile prosthe-
sis could control stress incontinence except in case of total 
sphincteric incontinence.
DISCUSSION
Urinary incontinence and ED are well-known adverse 
effects after an RP for PCa. All patients undergoing RP us-
ing any surgical approach, open, laparoscopic, or robotic, 
are at risk of developing urinary incontinence. According 
to the continence definition of ‘no pad’, 12-month urinary 
incontinence rates ranged from 4% to 31%, with a mean 
value of 16%. Various measures have been used for evalu-
ation of urinary incontinence, ranging from urodynamic 
studies to pad tests and self-reporting questionnaires in-
cluding the International Prostate Symptom Score quality 
of life  and the ICIQ-SF. These are useful tools to gauge pa-
tients’ perceptions, because they enable us to obtain in-
formation about voiding and other kinds of incontinence 
such as urge and stress incontinence. Furthermore, the 
pad test is viewed as a credible, non-invasive, effective test 
for quantifying urine loss, and is commonly used in re-
search as well as clinical practice
Most studies quantify incontinence accurately, with the 
number of pads being used as a marker of degree [13-15].
We did not use the validated instrument to assess incon-
tinence outcomes after surgery in every case. The surgeon 
was the primary data gatherer, following the operation 
with an interview. In men, urinary continence is thought 
to be controlled by five main structures: the detrusor mus-
cle, the internal sphincter, the trigonal muscles, the levator 
muscle, and the rhabdosphincter. The male urethral 
sphincter complex consists of a smooth muscle and skel-
etal muscle component. There are a number of explana-
tions as to the cause of post-prostatectomy incontinence, 
and it is likely that it is multifactorial in origin.
During a prostatectomy, the prostate, which has a de-
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gree of control over continence as part of the proximal 
sphincter unit, is removed. In addition, the proximal ure-
thral sphincter is lost; therefore, postoperative continence 
depends largely on the rhabdosphincter. Furthermore, the 
proximity of the neurovascular supply and rhabdosphinc-
ter to the prostate puts these structures at high risk of dam-
age intraoperatively. In addition to the urethral sphincter, 
the bladder is also affected by RP, with effects on detrusor 
innervation and function. Incontinence after RP can be 
broadly divided into two causes: urethral and detrusor. 
The urethral cause of incontinence has been found to be a 
result of either urethral sphincter incompetence, changes 
in urethral length, or strictures [16]. Multiple studies have 
demonstrated sphincter incompetence after RP. In the ma-
jority of patients with stress incontinence, it is likely a re-
sult of sphincter injury. Intrinsic sphincter deficiency on 
urodynamic testing is present in up to 88% of patients 
postoperatively. Urodynamic testing has shown that 
39.5% of post-RP patients have pure sphincteric in-
sufficiency, with only 18.5% demonstrating no sphinc-
teric involvement.
Maximal urethral closure pressure (MUCP) appears to 
be reduced postoperatively, with rates up to 41%. Similar 
results were demonstrated by Dubbelman et al [17], who 
reported significantly higher pre- and postoperative MUCP 
in men regaining continence at 6 months postoperatively 
compared with incontinent patients. They also stated that 
poor preoperative MUCP is an important prognostic factor 
for persistent incontinence postoperatively [18,19]. Nerve- 
sparing prostatectomy offers greater rates of continence 
due to neurovascular bundle preservation. It is likely that 
the combination of intraoperative nerve and neurovas-
cular damage has effects on both the detrusor and ureteric 
function, and this combination results in varying degrees of 
incontinence and ED depending on the amount of neuro-
vascular involvement.
In general, surgical intervention should be offered if the 
incontinence status is stable and no further improvement 
of continence can be achieved with conservative treat-
ment up to 12 months [20-22]. Among our patients, the 
mean duration of the wait for surgery was 3 years and 4 
months (6 months∼10 years). Conservative, non-invasive 
management of post-prostatectomy stress urinary incon-
tinence (SUI) includes lifestyle interventions, pelvic floor 
muscle training with or without biofeedback, and bladder 
training. In some patients with additional overactive blad-
der symptoms, additional antimuscarinic therapy is rec-
ommended as a first-line treatment [23,24]. The AUS is 
still the treatment of choice for persistent moderate to se-
vere incontinence. Despite a good success rate, the AUS 
does carry a risk of complications such as erosion, me-
chanical failure, and infection. The revision rates due to 
mechanical failure are reported to be 8% to 45% 
[10,25,26]. The first male slings for incontinence were de-
scribed by Berry [27] and Kaufman [28]; however, these 
slings fell out of favor because of low success rates and 
high complication rates. There have been several new, 
minimally invasive sling systems introduced recently for 
male SUI. Male slings are an alternative for men with SUI.
Nowadays, patient demand for minimally invasive 
treatment options is high and will drive the choice to use 
a sling. In recent years, numerous minimally invasive 
treatment options with different success rates have been 
investigated. Male slings showed promising results, but 
lower success rates may occur [29]. Almost every cur-
rently marketed male sling is implanted in the region of the 
bulbar urethra. Continence is achieved due to bulbar ure-
thral compression by these devices.
In fact, adjustability allows compression to be kept to a 
minimum, allowing for normal micturition without resi-
dual urine. Bulking agents such as collagen and silicone 
autologous fat should only be used in highly selected cas-
es due to the low success rate [30].
Our basic concept for this study was to increase the bul-
bar urethral closing pressure by self-inflation of an in-
flatable penile prosthesis, consequently preventing uri-
nary leakage. No reports are now available in regard to 
this new concept. Our study showed that urinary incon-
tinence could be controlled by inflating the penile pros-
thesis to some degree (from 30% up to full rigid erection) 
on an as-needed basis with a more than 72.2% success 
rate.
CONCLUSIONS 
Post-RP urinary incontinence can be controlled by in-
flating an inflatable penile prosthesis. Inflating the in-
flatable penile prosthesis from partial up to full rigidity in-
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creases the intra-urethral closing pressure, consequently 
preventing urinary leakage with an approximately 72.2% 
success rate. Therefore, especially in patients with the du-
al adverse problems of incontinence and ED after RP, the 
inflatable penile prosthesis is highly recommended as an 
initial surgical treatment.
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